The OHSU Knight Cancer Institute is a world leader in targeted therapy and early detection. Help us create a world free from the burden of cancer.
On Sept. 7 and 8, OHSU’s Knight Cancer Institute opened the doors to its new Knight Cancer Research Building — an innovative building that will house up to 650 cancer researchers and staff focused on the early detection of cancer. We spoke with attendees on what they thought of the building.
OHSU Knight Cancer Institute opened the doors to its new Knight Cancer Research Building — an innovative building designed to transform how cancer research is done.
A Q&A with Bree Mitchell, PhD, who leads strategic planning, scientific program development, organizational development, operations, and scientific collaboration building as the Associate Director of the OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR).
One of the most highly cited medical scientists in the world, Gordon Mills, M.D., will be joining the faculty of the OHSU Knight Cancer Institute. He will hold the new Wayne and Julie Drinkward Chair in Precision Oncology. The Drinkwards, who established the chair with a gift of $2.5 million to OHSU, are longtime supporters […]
“Our covenant with patients is to use philanthropic funds carefully, to make sure they are directed to making a difference.” Gordon Mills, M.D., Ph,D., director of precision oncology at the OHSU Knight Cancer Institutes, describes the impact that philanthropy has on cancer science.
Liberty Barnes, PhD, shares her cancer journey in this touching guest post. Liberty received treatment for breast cancer at OHSU.
OHSU announced that internationally renowned scientist Gordon B. Mills, MD, PhD, has been recruited to lead precision oncology for the Knight Cancer Institute. Here are a few interesting facts about him.
Gordon B. Mills, M.D., Ph.D., is the new director of precision oncology at the OHSU Knight Cancer Institute. His role will be to provide an “integrative force” across various efforts in progress at the institute, including the Cancer Early Detection Advanced Research (CEDAR) Center, immuno-oncology and the system biology groups. In this video, Mills talks […]
The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]
OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
